The size of the North America Burn Care Market has been calculated at USD 0.82 Billion in 2023. It is further estimated to reach USD 1.12 Billion by the end of 2028, showcasing a CAGR of 6.5% from 2023 to 2028.
Most companies focus on expanding their existence in the burn care product market by investing strategically in research and development activities, enabling them to launch new products in the market to have a competitive advantage. Most companies' main strategies in the burn care market are new product launches, collaborations, acquisitions, and expansions. New product launches' strategy accounted for the largest share of the overall growth strategies mapped from 2018 to 2023.
The Major factors that influence the growth of the market are a rise in the incidence of burns, i.e., over 1 million burn injuries were noticed annually in the U.S, growing Healthcare expenditure results in increased usage of skin grafts and advanced dressings, favorable government initiatives, increasing awareness in treatment options owing to increasing number emergency burn clinics.
However, the high cost of burn care treatments and the development of new products are the major factors that are challenging the market's growth.
This research report on the North America Burn Care Market has been segmented and sub-segmented into the following categories:
By Extent of Damage:
Advanced dressings are predicted to have the largest share in the market, while biologics is predicted to witness the highest CAGR during the forecast period. Increasing demand for Biologics in the U.S is driving the growth in North America.
The partial-thickness burns are expected to witness the market's highest share due to the increasing usage of biologics in the U.S. Among these, Hospitals usage is projected to witness the highest CAGR over the forecast period, owing to increasing awareness of treatment options
Some of the promising companies operating in the North America Burn Care Market Profiled in the Report are Smith & Nephew plc (U.K.), Acelity L.P (U.S.), 3M Company (U.S.), Molnlycke Health Care (Sweden), Derma Sciences Inc.(U.S.), Medtronic (Ireland), Coloplast A/S (Denmark), Convatec Inc (U.K.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com